Sanofi nabs FDA approval for Menactra booster; AZ's new Bydureon pen rolls out; Par restarts generic Precedex shipments;


@FiercePharma: Top-read on FP Monday: Bristol-Myers socks Merck's brand-new Keytruda with PD-1 patent suit. Article | Follow @FiercePharma

@EricPFierce: ICYMI yesterday: Action against AbbVie, Teva over AndroGel comes as FTC is stalking a $1B settlement this year. Report | Follow @EricPFierce

@CarlyHFierce: ICYMI yesterday: Latest Allergan buzz puts Ireland's Jazz in its dealmaking sights. Story | Follow @CarlyHFierce

Free Daily Newsletter

Like this story? Subscribe to FiercePharma!

Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on FiercePharma as their must-read source for the latest news, analysis and data on drugs and the companies that make them. Sign up today to get pharma news and updates delivered to your inbox and read on the go.

> Sanofi Pasteur won FDA approval for its Menactra vaccine as a booster shot against meningococcal disease in 15- to 55-year-olds. Release

> AstraZeneca ($AZN) said its new Bydureon pen for Type 2 diabetes is now available in the U.S. Report

> Par Pharmaceutical resumed shipping its version of Hospira's ($HSP) sedative Precedex after a U.S. court lifted a restraining order against the launch. Release

> A Washington, DC, federal judge refused to allow the consumer watchdog Public Citizen to access documents related to off-label marketing settlements involving Pfizer ($PFE) and Purdue Pharma. Report (reg. req.)

> Novartis ($NVS) sued two Indian drugmakers for patent infringement, targeting Zydus Pharmaceuticals' plans for a generic version of its Alzheimer's treatment, Exelon Patch, and Dr. Reddy's Laboratories' effort to knock off its cancer drug Gleevec. Report | Report

> U.S. Treasury Secretary Jack Lew called for quick action against tax inversion deals, such as AbbVie's ($ABBV) planned buyout of Shire ($SHPG). Report

> Pfizer Canada donated EpiPen injectors as part of a pilot project aimed at making the anaphylaxis-fighter available at every restaurant and food court in Hamilton, Ontario. Report

Medical Device News

@FierceMedDev: GE Healthcare, FBI allege Chinese engineer stole MRI trade secrets. FierceDiagnostics story | Follow @FierceMedDev

@VarunSaxena2: EU creates €1B fund for research on the use of graphene. Article | Follow @VarunSaxena2

@MichaelGFierce: ICYMI: UO, Berkeley team tailors ultrathin peptoid nanosheets for delivery using oil and water. More from FierceDrugDelivery | Follow @MichaelGFierce

@EmilyWFierce: J&J ordered to fork over $3.27M in vaginal mesh case. Report | Follow @EmilyWFierce

> Israeli startup develops hand-held device for medical marijuana. Report

> Titan Spine offers first spine implant warranty. More

> Stent developer Tryton gets $20M to complete FDA submission, market in EU. Story

Biotech News

@FierceBiotech: Christoph Westphal launches another biotech, with the help of some wealthy friends. Story | Follow @FierceBiotech

@JohnCFierce: Can Novo Nordisk and Orexigen finally open up a blockbuster weight-loss market? More | Follow @JohnCFierce

@DamianFierce:   | Follow @DamianFierce

@EmilyMFierce: Great tool for journalists covering NIH budget: @UMR4NIH launched an interactive map that breaks down state funding. More | Follow @EmilyMFierce

> OrbiMed Advisors banks $325M for a new round of Asian biotech bets. Report

> Boehringer's next-gen COPD treatment hits the mark in Phase III. Article

> PRA lines up a $375M IPO after a string of CRO deals. Story

Biotech Research News

> Compound inhibits both MERS, SARS. Report

> Experimental C. difficile drugs could be more effective than current therapy. Article

> Glaxo's Ebola vaccine effective in monkeys but may require booster shot. More

> 'Disease in a dish' aids Huntington's drug discovery. Item

> Scientists find way to expand blood stem cell production in lab. Story

Pharma Manufacturing News

> ProBioGen will double its Berlin staff to expand cell-based manufacturing. Article

> Germany's Aenova buys North Carolina packaging operation. Item

> Cipla buys two Indian manufacturing facilities for partner Okasa. Story

> Perrigo recalls 367,000 tubes of nicotine lozenges. Report

> FDA, DOJ arrest NECC pharmacist about to leave the country. Article

And Finally... Health officials identified an unusual, serious outbreak of enterovirus in children in the Midwest. Report

Suggested Articles

In an era of limited access to key decision makers, how are you mobilizing your field force to communicate the value of your brands and real-world evidence?

Novo Nordisk’s Ozempic is off to a blazing start, and the company just threw more fuel on the fire with a pair of trial wins.

Biosims to Roche's Big 3 cancer drugs will chisel out a $10 billion sales gap by 2023, but newer meds could chip in $16.3 billion, the drugmaker says.